ERK1/2 pT202/pY204 Antibody, anti-human/mouse, REAfinity™
Synonyms: MAPK1, MAPK3, ERK, ERK-2, ERK-1
RECOMBINANT EXTENDED VALIDATION
Bioz Star90/100 Bioz rating
3 Citations
Clone:
REA152 | 20A
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for ERK1/2 pT202/pY204 Antibody, anti-human/mouse, REAfinity™

Intracellular flow cytometry applications
APC
PE
PerCP-Vio 700
Recommended dilution:
1:11
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-103-686, 130-103-621
Description:
Human peripheral blood mononuclear cells (PBMCs), either left unstimulated (left peak) or stimulated with 40 nM phorbol myristate acetate (PMA) for 10 minutes, were fixed and then permeabilized with the Cell Signaling Buffer Set A. Cells were then stained with Anti-ERK1/2 pT202/pY204 antibodies and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application image
Extended validation for ERK1/2 pT202/pY204 Antibody, anti-human/mouse, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA152
20A
high
MILAN8R
partial
6B8B69
high
4B11B69
high

Cells were incubated with an excess of purified unconjugated ERK1/2 pT202/pY204 (REA152) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for ERK1/2 pT202/pY204. Human peripheral blood mononuclear cells (PBMCs) were stimulated with 40nM PMA for 10 min at 37°C. Cells were stained with ERK1/2 pT202/pY204 antibodies and plotted against the side scatter. As a control, ERK1/2 pT202/pY204 antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant® Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for ERK1/2 pT202/pY204 Antibody, anti-human/mouse, REAfinity™
Overview

Clone REA152 recognizes the phosphorylated threonine 202 and tyrosine 204 (pT202/pY204) of human ERK1 and pT184/pY186 of human ERK2, which are key components of the MAPK signaling cascade. ERK1 and ERK2 are multifunctional serine/threonine kinases and are ubiquitously expressed in mammalian cells. They share 85% homology and are phosphorylated by kinases MEK1/2 at Thr and Tyr residues within their activation loop leading to activation and nuclear translocation of ERKs. Activated ERKs phosphorylate downstream targets, such as signaling effectors, receptors, cytoskeletal proteins, and transcription factors. Owing to such a wide array of cellular targets, ERKs are involved in regulation of a number of processes including cell adhesion, cell cycle progression, cell migration, cell survival, differentiation, metabolism, proliferation, and transcription. Activation and mobilization of ERKs is induced in response to several extracellular signals and engagement of receptors such as Tyr kinases (RTKs), G protein–coupled receptors (GPCRs), ion channels, and others. The ERK1/2 are dual specificity kinases and phosphorylate Ser or Thr residues neighbor to Proline residue.

Additional information: Clone REA152 displays negligible binding to Fc receptors.

Alternative names

MAPK1, MAPK3, ERK, ERK-2, ERK-1

Detailed product information

Technical specifications

Clone
REA152
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat
Cross-reactivity
rat
Antigen
ERK1/2 pT202/pY204
Molecular mass of antigen [kDa]
42
Distribution of antigen
other
Entrez Gene ID
RRID
AB_2651669, AB_2651664, AB_2651666, AB_2651665, AB_2651668, AB_2651667

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for ERK1/2 pT202/pY204 Antibody, anti-human/mouse, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support